TNF and rheumatoid arthritis: This notion is synonymous with how single-agent biologics, such as TNF-α antagonists, are thought to ameliorate the progression of autoimmune disorders in vivo (e.g., rheumatoid arthritis or Crohn’s disease) characterized by complex inflammatory networks.